Related references
Note: Only part of the references are listed.BMX Represses Thrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis
Li Zhao et al.
CIRCULATION RESEARCH (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
COVID-19 and its implications for thrombosis and anticoagulation
Jean M. Connors et al.
BLOOD (2020)
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action
Anastasios Kollias et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
COVID-19: treating and managing severe cases
Jingwen Ai et al.
CELL RESEARCH (2020)
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Huan Han et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
The amount of cytokine-release defines different shades of Sars-Cov2 infection
S. Bindoli et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Betsy J. Barnes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis
Long-quan Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Jean-Francois Llitjos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
SARS-CoV-2 and viral sepsis: observations and hypotheses
Hui Li et al.
LANCET (2020)
On the Alert for Cytokine Storm: Immunopathology in COVID-19
Lauren A. Henderson et al.
ARTHRITIS & RHEUMATOLOGY (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany
Carolin Edler et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2020)
Coagulation abnormalities and thrombosis in patients with COVID-19
Marcel Levi et al.
LANCET HAEMATOLOGY (2020)
Coagulation disorders in coronavirus infected patients: COVID-19, SARS- CoV-1, MERS-CoV and lessons from the past
Dimitrios Giannis et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
COVID-19-associated coagulopathy: An exploration of mechanisms
Meaghan E. Colling et al.
VASCULAR MEDICINE (2020)
Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content
Fatma Beyazit et al.
MEDICAL HYPOTHESES (2020)
Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis
Ricardo J. Jose et al.
EUROPEAN RESPIRATORY REVIEW (2020)
The values of coagulation function in COVID-19 patients
Xin Jin et al.
PLOS ONE (2020)
Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
Isis Venturi Biembengut et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Furin-mediated protein processing in infectious diseases and cancer
Elisabeth Braun et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity
Naveen Gupta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Mechanisms and treatment of organ failure in sepsis
Christophe Lelubre et al.
NATURE REVIEWS NEPHROLOGY (2018)
PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury
Karen De Ceunynck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Neurovirulent Murine Coronavirus JHM. SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion
Judith M. Phillips et al.
JOURNAL OF VIROLOGY (2017)
More than an anticoagulant: Do heparins have direct anti-inflammatory effects?
Timothy J. Poterucha et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Targeting PAR1: Now What?
Robert Flaumenhaft et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease
Rebecca J. Gryka et al.
DRUGS IN R&D (2017)
New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey
Toshiaki Iba et al.
BMJ OPEN (2017)
Proteinases, Their Extracellular Targets, and Inflammatory Signaling
Rithwik Ramachandran et al.
PHARMACOLOGICAL REVIEWS (2016)
Proteases and oxidant stress control organic dust induction of inflammatory gene expression in lung epithelial cells
Kartiga Natarajan et al.
RESPIRATORY RESEARCH (2016)
Proteinase-activated receptors in fibroproliferative lung disease
Ricardo J. Jose et al.
THORAX (2014)
Modulation of Protease Activated Receptor 1 Influences Human Metapneumovirus Disease Severity in a Mouse Model
Laetitia Aerts et al.
PLOS ONE (2013)
Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Lisa E. Gralinski et al.
MBIO (2013)
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46
Laurent O. Mosnier et al.
BLOOD (2012)
Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases
Gero L. Becker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis
Sarah L. Tressel et al.
EMBO MOLECULAR MEDICINE (2011)
Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
Jianshe Lang et al.
PLOS ONE (2011)
Inflammation and coagulation
Marcel Levi et al.
CRITICAL CARE MEDICINE (2010)
Role of Protease Activated Receptor 2 in Experimental Acute Lung Injury and Lung Fibrosis
Xiao Su et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2009)
Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis
Xiaopeng Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Inflammation, endothelium, and coagulation in sepsis
Marcel Schouten et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Matrix metalloproteinases and matrix metatioproteinase inhibitors in acute lung injury
SEG Fligiel et al.
HUMAN PATHOLOGY (2006)
Neutrophil and pathogen proteinases versus proteinase-activated receptor-2 lung epithelial cells - More terminators than activators
M Chignard et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function
F Guessous et al.
INFECTION AND IMMUNITY (2005)
Two-way interactions between inflammation and coagulation
M Levi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Protease-activated receptors in hemostasis, thrombosis and vascular biology
SR Coughlin
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis
DCJ Howell et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Protease-activated receptors: Contribution to physiology and disease
VS Ossovskaya et al.
PHYSIOLOGICAL REVIEWS (2004)
A model of the ACE2 structure and function as a SARS-CoV receptor
P Prabakaran et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
K Okajima
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Gene expression profiling of inflamed human endothelial cells and influence of activated protein C
N Franscini et al.
CIRCULATION (2004)
Bidirectional relation between inflammation and coagulation
M Levi et al.
CIRCULATION (2004)
Molecular recognition in the protein C anticoagulant pathway
B Dahlbäck et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
A cell-based model of hemostasis
M Hoffman et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
Share Paper
